Purple Biotech
PPBT
9 hedge funds and large institutions have $134K invested in Purple Biotech in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
36% less funds holding
Funds holding: 14 → 9 (-5)
64% less capital invested
Capital invested by funds: $378K → $134K (-$244K)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$39.2K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$639 |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$288 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$72.1K |
| 2 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
-$53.7K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$27.4K |
| 4 |
Morgan Stanley
New York
|
-$2.08K |
| 5 |
CWM
Crowley Wealth Management
Wilmington,
Delaware
|
-$1.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $61.2K | +$39.2K | +1,225 | +114% |
|
|
KWA
2
Kingswood Wealth Advisors
San Diego,
California
| $44.3K | -$53.7K | -1,679 | -50% |
|
3
BNP Paribas Financial Markets
Paris,
France
| $14.3K | – | – | – |
|
|
4
Morgan Stanley
New York
| $11.9K | -$2.08K | -65 | -13% |
|
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $2.19K | +$639 | +20 | +33% |
|
|
6
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $226 | +$288 | +9 | New |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $53 | -$543 | -17 | -89% |
|
|
NSIM
8
North Star Investment Management
Chicago,
Illinois
| $40 | – | – | – |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$72.1K | -1,537 | Closed |
|
|
10
Group One Trading
Chicago,
Illinois
| – | -$27.4K | -857 | Closed |
|
|
CWM
11
Crowley Wealth Management
Wilmington,
Delaware
| – | -$1.41K | -30 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$1.06K | -23 | Closed |
|
|
TWC
13
TD Waterhouse Canada
Toronto,
Ontario, Canada
| – | -$938 | -20 | Closed |
|
PPBT Hedge Fund Activity: Q1 2025 in Review
9 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2025, worth a combined $134K — down 64% from $378K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PPBT and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $39.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $72.1K sold.
- 9 institutional investors held Purple Biotech (PPBT) as of Q1 2025, down from 14 in Q4 2024.
- Funds reported $134K of Purple Biotech stock for Q1 2025, down 64% quarter-over-quarter.
- 1 fund opened new Purple Biotech positions in Q1 2025 and 5 closed out, a net change of -4 holders.
- The largest Purple Biotech buyer in Q1 2025 was UBS Group, an estimated $39.2K added.
- The largest Purple Biotech seller in Q1 2025 was Two Sigma Securities, an estimated $72.1K sold.
Based on aggregated 13F filings for Q1 2025.